Literature DB >> 6253639

Increased incidence of symptomatic cholesterol cholelithiasis in perimenopausal women receiving estrogen replacement therapy: a retrospective study.

L H Honoré.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6253639

Source DB:  PubMed          Journal:  J Reprod Med        ISSN： 0024-7758            Impact factor:   0.142


× No keyword cloud information.
  4 in total

1.  Alterations in gallbladder emptying and bile retention in the absence of changes in bile lithogenicity in postmenopausal women on hormone replacement therapy.

Authors:  Radha K Dhiman; Pralay K Sarkar; Arpita Sharma; Kala Vasishta; Krishan K Kohli; Sanjay Gupta; Sudha Suri; Yogesh Chawla
Journal:  Dig Dis Sci       Date:  2004-08       Impact factor: 3.199

Review 2.  Hepatobiliary complications of oral contraceptives.

Authors:  M C Lindberg
Journal:  J Gen Intern Med       Date:  1992 Mar-Apr       Impact factor: 5.128

3.  The deletion of the estrogen receptor α gene reduces susceptibility to estrogen-induced cholesterol cholelithiasis in female mice.

Authors:  Ornella de Bari; Helen H Wang; Piero Portincasa; Min Liu; David Q-H Wang
Journal:  Biochim Biophys Acta       Date:  2015-07-30

Review 4.  Is the oral contraceptive or hormone replacement therapy a risk factor for cholelithiasis: A systematic review and meta-analysis.

Authors:  Siqi Wang; Yuqiong Wang; Jinming Xu; Yuxin Chen
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.